ClosedNo longer accepting applications
Targeted Genome Editor Delivery (TARGETED) Challenge
National Institute of Health (NIH)
About this archived opportunity
Develop programmable delivery systems and non-viral delivery across the blood-brain barrier. Apply to develop new ways to deliver genome-editing tools inside the body. NIH is looking for early-stage ideas or solutions for delivery systems for genome editors in two areas: programmable delivery systems and non-viral delivery across the blood-brain barrier.
Historical details
- Status
- Closed
- First captured
- March 27, 2026
- Award
- $6,000,000
- Publisher reference
- https://www.usa.gov/challenges/nih-targeted-genome-editor-delivery
This opportunity has closed
Targeted Genome Editor Delivery (TARGETED) Challenge
by National Institute of Health (NIH)
Get notified when similar opportunities open
We'll save this search and email you when new targeted, genome, editor opportunities are posted. Free.
Related opportunities
- BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)National Institutes of HealthCloses Feb 2027
- Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)National Institutes of HealthCloses Oct 2027
- BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed)National Institutes of HealthCloses Jun 2027
- Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional)National Institutes of HealthCloses Feb 2027
- Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)National Institutes of HealthCloses Feb 2028
- BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed)National Institutes of HealthCloses Jan 2027Up to $750K